Cancel

Current Trends in the Management of Castration-Resistant Prostate Cancer

STATEMENT OF NEED Prostate cancer is the most common tumor type in men in the United States. Typically, androgen deprivation therapy is administered for progressive disease. However, castration resistance or unresponsiveness to androgen deprivation therapy or to antiandrogens frequently develops over time. The transition from castration-sensitive to castration-resistant disease has yet to be understood and represents a significant unmet need. Nonmetastatic castration-resistant prostate canc...
i3 Health

Optimizing Treatment Experiences in Castration-Resistant Prostate Cancer

STATEMENT OF NEED Prostate cancer is the most common tumor type in men in the United States. Typically, androgen deprivation therapy is administered for progressive disease. However, castration resistance or unresponsiveness to androgen deprivation therapy or to antiandrogens frequently develops over time. The transition from castration-sensitive to castration-resistant disease has yet to be understood and represents a significant unmet need. Nonmetastatic castration-resistant prostate canc...
i3 Health

Compounding for Hormone Replacement Therapy

COMPOUNDING FOR HORMONE REPLACEMENT THERAPY is an accredited 15 hour (1.5 CEUs) practice-based course designed for pharmacists, technicians, marketers, and students who want to learn more about a growing segment for compounding. Physicians and other healthcare professionals are welcome to attend. Using the basic components of compounding, HRT can be the cornerstone of a successful pharmacy with a diversified practice. Participants will gain a comprehensive knowledge of how and why a patient an...
American College of Apothecaries

Internal Medicine Comprehensive Review and Update 2019

This CME program from the leading clinical faculty of Harvard Medical School and Massachusetts General Hospital provides comprehensive instruction to ensure clinicians are current with the latest evidence and best practices for: • Cardiovascular Medicine • Pulmonary Medicine • Critical Care • Hematology and Oncology • Mind-Body Medicine • Infectious Diseases • Gastroenterology • Endocrinology • Rheumatology • Nephrology • Travel Medicine • Allergy and Immuno...
Harvard Medical School

The Brigham Board Review in Oncology: Brigham and Women's Hospital and Oakstone Board Review

Topics covered by The Brigham Board Review in Oncology include: Molecular Genetics of Cancer, Cancer Drug Development, Infections in Cancer Patients, Head and Neck Cancer, Thyroid Cancer, Pancreatic and Hepatobiliary Cancer, Renal and Bladder Cancer, Prostate Cancer and many others. Studying The Brigham Board Review in Oncology will better prepare you to: • Apply current/recommended Oncology guidelines in clinical practice • Perform differential diagnosis of complex Oncologic disorders...
CMEInfo

Current Topics in Family Medicine, Internal Medicine and Gastroenterology Canada and NE Discovery Cruise

1. Ambulatory Management of Congestive Heart Failure 2. Dizziness - the diagnostic and management conundrum 3. Oral Hypoglycemic Medications for type 2 DM management - what is the evidence? 4. Office Emergencies - management without disruption 5. Steroid Joint Injections - minimal effort and maximal benefit 6. Food as a prescription 7. Lower Extremity Deep Venous Thrombosis Diagnosis - How and Why? 8. Prostate Cancer Update 9. Exercise is "The New pill" 10. Di...
Continuing Education, Inc

Compounding for Hormone Replacement Therapy

COMPOUNDING FOR HORMONE REPLACEMENT THERAPY is an accredited 15 hour (1.5 CEUs) practice-based course designed for pharmacists, technicians, marketers, and students who want to learn more about a growing segment for compounding. Physicians and other healthcare professionals are welcome to attend. Using the basic components of compounding, HRT can be the cornerstone of a successful pharmacy with a diversified practice. Participants will gain a comprehensive knowledge of how and why a patient an...
American College of Apothecaries

Preventive Health for Adults: Current Screening Guidelines for Heart Disease and Cancer

To achieve the Triple Aim of Healthcare (better care, better health, and lower costs), it is critical that primary care providers be aware of appropriate means of disease prevention and detection, particularly for heart disease and cancer, the two leading causes of death in the US. This session is specially designed for internists, family practitioners, and other primary care clinicians. After completing this activity, participants will be better able to implement the latest evidence-based...
Rockpointe

Nursing Management of Bone Health in Patients With Cancer

STATEMENT OF NEED Many tumors, such as prostate, breast, lung, and multiple myeloma, affect bone health. Once cancer spreads to the skeletal system, the risk for pain, fractures, hypercalcemia, and nerve compression increases considerably. Several studies have shown that the use of antiresorptive agents such as bisphosphonates and monoclonal antibodies can reduce the morbidity of skeletal complications in patients with cancer and significantly improve quality of life. Combined with preventi...
i3 Health

Nuclear Medicine and Molecular Imaging Essentials

Meetings By Mail presents Nuclear Medicine and Molecular Imaging Essentials, the Mid-Eastern Chapter of the Society of Nuclear Medicine and Molecular Imaging's 47th Annual Meeting. The activity details nuclear medicine's impact on radiology, cardiology, oncology, neurology and much more. Topics include Nuclear Cardiology, Neuroimaging, Body Imaging, Safety Precautions, Practice Enhancements and much more. After viewing Nuclear Medicine and Molecular Imaging Essentials, you should be able to:...
Meetings by Mail

Osler Surgery MOC Online Review

The Osler Institute utilized state of the art equipment to record the comprehensive Radiation Oncology Review Course and bring it to you! These audio files are stored “in the cloud” so you can stream them anywhere, anytime, as long as you have an internet connection – your learning experience is almost like being at the live activity, but without travel costs and time away from your practice. The Osler Radiation Oncology Review also offers a variety of live Radiation Oncology board revie...
Osler Institute

New Drugs 2018

In 2018, the US Food and Drug Administration (FDA) approved 59 new drugs – the highest number in more than 10 years – including 19 first-in-class agents. Of the 59 new approvals, 73% received priority review. This issue of The Rx Consultant focuses on the new drugs that may be important additions (including a number of “firsts”) in their therapeutic areas: influenza infection, HIV-1 infection, pneumonia and skin infections, nonmetastatic, castration-resistant prostate cancer, endome...
The Rx Consultant

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.